|
|
Volumn 148, Issue 5, 2008, Pages 400-402
|
|
Trials that matter: The effect of a fixed-dose combination of an angiotensin-converting enzyme inhibitor and a diuretic on the complications of type 2 diabetes
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMLODIPINE;
ANGIOTENSIN RECEPTOR ANTAGONIST;
BENAZEPRIL;
CANDESARTAN;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
GLICLAZIDE;
HYDROCHLOROTHIAZIDE;
INDAPAMIDE;
LISINOPRIL;
PERINDOPRIL;
PLACEBO;
THIAZIDE DIURETIC AGENT;
ANTIHYPERTENSIVE AGENT;
DIURETIC AGENT;
ADD ON THERAPY;
CLINICAL TRIAL;
COUGHING;
DIASTOLIC BLOOD PRESSURE;
DIZZINESS;
DRUG DOSE TITRATION;
EDITORIAL;
HUMAN;
HYPERTENSION;
HYPOTENSION;
MICROANGIOPATHY;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PRIORITY JOURNAL;
SYSTOLIC BLOOD PRESSURE;
DIABETIC ANGIOPATHY;
DRUG COMBINATION;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
ANTIHYPERTENSIVE AGENTS;
CLINICAL TRIALS AS TOPIC;
DIABETES MELLITUS, TYPE 2;
DIABETIC ANGIOPATHIES;
DIURETICS;
DRUG THERAPY, COMBINATION;
HUMANS;
HYPERTENSION;
INDAPAMIDE;
PERINDOPRIL;
|
|
EID: 41049109552
PISSN: 00034819
EISSN: None
Source Type: Journal
DOI: 10.7326/0003-4819-148-5-200803040-00012 Document Type: Editorial |
|
Times cited : (4)
|
|
References (20)
|
